Zimmer Biomet is reducing its global workforce by approximately 3%.
According to a statement from Zimmer Biomet today, “In order to create and sustain a framework of operational excellence across Zimmer Biomet, we are making changes to further enhance our execution, commercial focus and how we collaborate. We will be reallocating investments and resources to best position the company for long-term growth, which includes last week’s announcement to reduce headcount by approximately 3% of the more than 18,000 total current global ZB team member positions.
“Simplification of our processes, our structure and how we work is key to delivering on our strategy, and we remain confident in our ability to execute as we continue to deliver on our mission to alleviate pain and improve the quality of life for people around the world.”
Other local orthopedic companies also announced layoffs recently, including Tecomet and DePuy-Synthes.
On Jan. 28, a spokesperson from DePuy Synthes said, “As the world’s largest, most diversified healthcare company, we are constantly assessing ways to be more innovative and competitive. We are evolving amidst a rapidly changing environment and as our supply chain stabilizes our network is adjusting production requirements. As a result, DePuy Synthes is changing its operating model at our manufacturing site in Warsaw to better align with current business needs. We recognize the potential impact to our employees because of these changes and are committed to providing them with the appropriate support.
“Our manufacturing site continues to be a strategic site for our DePuy Synthes business.”